Skip to main content
TipRanks
Go Ultimate75% OFF

YUNGJIN PHARM. CO. LTD (003520) Stock Statistics & Valuation Metrics

Total Valuation

YUNGJIN PHARM. CO. LTD has a market cap or net worth of KRW 139.36B. The enterprise value is KRW 258.67B.

Market Cap
KRW 139.36B
Enterprise Value
KRW 258.67B

Share Statistics

YUNGJIN PHARM. CO. LTD has 182,892,730 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
182,892,730
Owned by Insiders
―
Owned by Institutions
1.92%

Financial Efficiency

YUNGJIN PHARM. CO. LTD’s return on equity (ROE) is -0.00 and return on invested capital (ROIC) is 1.64%.

Return on Equity (ROE)
-0.00
Return on Assets (ROA)
-0.00
Return on Invested Capital (ROIC)
1.64%
Return on Capital Employed (ROCE)
0.02
Revenue Per Employee
406.16M
Profits Per Employee
-363.68K
Employee Count
626
Asset Turnover
0.97
Inventory Turnover
2.70

Valuation Ratios

The current PE Ratio of YUNGJIN PHARM. CO. LTD is -17.72. YUNGJIN PHARM. CO. LTD’s PEG ratio is 0.03.

PE Ratio
-17.72
PS Ratio
0.55
PB Ratio
1.68
Price to FCF
-13.82
Price to Operating Cash Flow
-25.89
PEG Ratio
0.03

Income Statement

In the last 12 months, YUNGJIN PHARM. CO. LTD had revenue of 254.26B and earned -227.66M in profits. Earnings per share was -1.24.

Revenue
254.26B
Gross Profit
75.86B
Operating Income
3.42B
Pretax Income
-212.00M
Net Income
-227.66M
EBITDA
12.20B
Earnings Per Share (EPS)
-1.24

Cash Flow

In the last 12 months, operating cash flow was -2.85B and capital expenditures -5.49B, giving a free cash flow of -8.34B billion.

Operating Cash Flow
-2.85B
Free Cash Flow
-8.34B
Free Cash Flow per Share
-55.13

Dividends & Yields

YUNGJIN PHARM. CO. LTD pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-7.23%
Earnings Yield
-5.64%

Stock Price Statistics

Beta
0.18
52-Week Price Change
-62.65%
50-Day Moving Average
987.50
200-Day Moving Average
1373.34
Relative Strength Index (RSI)
21.87
Average Volume (3m)
368.75K

Important Dates

YUNGJIN PHARM. CO. LTD upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

YUNGJIN PHARM. CO. LTD as a current ratio of 1.48, with Debt / Equity ratio of 102.77%

Current Ratio
1.48
Quick Ratio
0.81
Debt to Market Cap
0.24
Net Debt to EBITDA
5.37
Interest Coverage Ratio
0.82

Taxes

In the past 12 months, YUNGJIN PHARM. CO. LTD has paid 15.66M in taxes.

Income Tax
15.66M
Effective Tax Rate
-0.07

Enterprise Valuation

YUNGJIN PHARM. CO. LTD EV to EBITDA ratio is 894.41, with an EV/FCF ratio of -20.90.

EV to Sales
0.83
EV to EBITDA
894.41
EV to Free Cash Flow
-20.90
EV to Operating Cash Flow
-39.14

Balance Sheet

YUNGJIN PHARM. CO. LTD has KRW 3.59B in cash and marketable securities with KRW 77.24B in debt, giving a net cash position of -KRW 73.66B billion.

Cash & Marketable Securities
KRW 3.59B
Total Debt
KRW 77.24B
Net Cash
-KRW 73.66B
Net Cash Per Share
-KRW 402.73
Tangible Book Value Per Share
KRW 458.36

Margins

Gross margin is 31.03%, with operating margin of -2.60%, and net profit margin of -3.09%.

Gross Margin
31.03%
Operating Margin
-2.60%
Pretax Margin
-3.82%
Net Profit Margin
-3.09%
EBITDA Margin
0.09%
EBIT Margin
-2.60%

Analyst Forecast

The average price target for YUNGJIN PHARM. CO. LTD is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
1.83%
EPS Growth Forecast
-860.37%

Scores

Smart Score
―
AI Score
40